📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

IL-15/IL-15Ra/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. (2018)

First Author: Shi Y

Attributed to: Large scale lentiviral vector production funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2018019026

PubMed Identifier: 30482760

Publication URI: http://europepmc.org/abstract/MED/30482760

Type: Journal Article/Review

Volume: 2

Parent Publication: Blood advances

Issue: 22

ISSN: 2473-9529